Seasoned leadership. A wealth of experience.

Our Leadership Team

Our leadership team is made up of highly experienced executives with proven track records
of success in the biotechnology and biopharmaceutical industries.

David Meek

President & CEO, Director

“Creating a strong corporate culture is critical to our success. I believe that a culture built on a foundation of shared purpose, common values and authenticity will drive innovation and help us transform patient care.”

David Meek was appointed as the first CEO soon after FerGene was created. He has over 30 years of biopharma experience commercializing and developing innovative medicines for patients across a range of therapeutic areas.

Before moving to FerGene, David was the Chief Executive Officer (CEO) and a Board Member of Ipsen where he was responsible for delivering industry-leading sales and shareholder growth of a global biopharma focused on oncology and specialty care. David has also held several executive leadership positions including Executive Vice President and President of Baxalta Oncology prior to its acquisition by Shire; CCO of Endocyte; Region Head, Novartis Oncology; CEO of Novartis Canada, and Global Franchise Head. He began his biopharma career at Johnson & Johnson and Janssen Pharmaceutica. David also serves on the board of directors for two publicly traded biotech companies, uniQure (QURE) and Entasis (ETTX). David has been active throughout his career to enhance the innovation agenda of the biopharma industry. He has previously served as an industry member of the board of directors of the Pharmaceutical Research Manufacturers of America (PhRMA), the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the European Federation of Pharmaceutical Industry Association (EFPIA).

Prior to his biopharma career, David was a commissioned officer in the United States Army, where he was awarded the Bronze Star Medal.

Ambaw Bellete

Chief Operating Officer

Wendy DiCicco

Interim CFO

Brad Hartman

Chief People Officer

Vijay Kasturi, MD

Vice President,
Medical Affairs

Peter Olagunju

Senior Vice President,
Technical Operations

Michael Seckler

Senior Vice President,
Operations

Dominic Moorhead

Dominic Moorhead is Executive Vice President and Chief Financial Officer at Ferring Pharmaceuticals. In this role, he is responsible globally for Finance, Information Technology, Procurement and Internal Audit.

He has more than 30 years of finance and business experience in the life sciences industry. Prior to joining Ferring Pharmaceuticals in 2017, Dominic held senior leadership roles at Takeda, and prior to that served as CFO at Roche Pharmaceuticals.

A graduate of the University of Nottingham in the UK, he holds a degree in Chemistry and is a UK Chartered Accountant.

Paris Panayiotopoulos, MS

Aaron Graff, MBA

David Meek

Jean Frederic Paulsen

Evan Rachlin

William Young

Want to build your future with our team of trailblazers?